Blog Viewer

Albany Neurocritical Care Among First Neuro ICU Teams to Get COVID-19 Vaccine

By Currents Editor posted 12-23-2020 09:18

  

By Tamer Abdelhak, MD, FNCS 

On Monday, Dec. 14, 2020, the Albany Medical Center neurocritical care team was one of the first Neuro ICU teams to receive the Pfizer COVID-19 vaccine. The team has been on the frontline of managing patients within Upstate New York who have suffered from catastrophic neurologic injuries, some with concomitant COVID-19 infection.

New York State was one of the most affected areas in the United States during the April 2020 surge of COVID pandemic. Albany Medical Center is a Level 1 trauma center and the Capital Region's only comprehensive stroke center, serving 3 million people in Upstate New York. The NeuroICU at Albany Medical Center is the region's only Neuro ICU, covering patients with catastrophic neurological injuries at a 15-bed capacity. 

Tamer Abdelhak, MD, medical director of the Albany Medical Center Neuro ICU; Teresa Caringi, FNP; and Jacquie Sayers, PAC pose after receiving their first COVID-19 vaccine.

 

Tamer Abdelhak, MD, medical director of the Albany Medical Center Neuro ICU; Teresa Caringi, FNP; and Jacquie Sayers, PAC, pose with Dennis Mckenna, MD, CEO of Albany Medical Center.

 #NCSRoundup

FURTHER READING
“Stories of Hope” is a popular column on the Neurocritical Care Society’s Currents content center. This series has been uplifting patients and providers alike since its founding. To support NCS’s Curing Coma ® initiative, which aims to develop and implement coma treatment strategies that improve ...
Verticalization for Refractory Intracranial Hypertension: A Case Series Neurocritical Care (08/17/21) DOI: 10.1007/s12028-021-01323-z Lachance, Brittany Bolduc; Chang, WanTsu; Motta, Melissa; et al. https://link.springer.com/article/10.1007%2Fs12028-021-01323-z   Researchers present ...
Hana Nobleza, Marin Darsie, H.E. Hinson, Deepa Malaiyandi, and Diana Greene-Chandos The past year has been hard for all of us. Our resilience, commitment and passion to our patients, and profession have been put to the test. Despite the challenge that the year brought, the Inclusion in Neurocritical ...